25-Hydroxyvitamin D Is Associated with Islet Homeostasis in Type-2 Diabetic Patients with Abdominal Obesity

Abstract

Objective

Islet α cells input is essential for insulin secretion from β cells. The present study aims to investigate the association between 25-hydroxyvitamin D [25(OH)D] and islet function homeostasis in type-2 diabetes (T2D) patients.

Methods

A total of 4670 T2D patients from seven communities in Shanghai, China were enrolled. The anthropometric indices, biochemical parameters, serum 25(OH)D, and islet function [including C-peptide (C-p) and glucagon] were measured.

Results

The fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), glucagon, and C-p levels exhibited a significantly decreasing trend in T2D patients as the 25(OH)D levels increased. Next, the population was divided into two groups: abdominal obesity and non-abdominal obesity groups. After adjustment, the 25(OH)D level was found to be associated with HbA1c, glucagon, and homeostasis model assessment of β (HOMA-β) in the non-abdominal obesity group. There was a significant relationship between 25(OH)D and HbA1c, glucagon, HOMA-IR, baseline insulin or C-p in the abdominal obesity group. In the abdominal obesity group, the ordinary least squares (OLS) regression and quantile regression revealed that 25(OH) D was obviously associated with glucagon and fasting C-p levels. In the abdominal obesity group, the moderate analysis revealed a significant interaction effect of 25(OH)D and glucagon on C-p (P=0.0124). Furthermore, the conditional indirect effect of 25(OH)D on the glucagon/C-p ratio was significantly lower at 1 standard deviation (SD) below the mean (P=0.0002), and lower at the mean of the course of diabetes (P=0.0007).

Conclusion

25(OH)D was found to be negatively correlated to glucagon and C-p in T2D patients with abdominal obesity. The 25(OH)D influenced C-p in part by influencing glucagon. The effect of 25(OH)D on the glucagon/C-p ratio in T2D patients with abdominal obesity, in terms of islet homeostasis, is influenced by the course of diabetes.

Keywords

25-hydroxyvitamin D / glucagon / C-peptide / islet α cells / islet β cells / type-2 diabetes

References

[1] SvendsenB, LarsenO, GabeMBN, et al.. Insulin Secretion Depends on Intra-islet Glucagon Signaling. Cell Rep, 2018, 25(5): 1127-1134

[2] AckermannAM, WangZ, SchugJ, et al.. Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol Metab, 2016, 5(3): 233-244

[3] CapozziME, WaitJB, KoechJ, et al.. Glucagon lowers glycemia when beta-cells are active. JCI Insight, 2019, 5(16): e129954

[4] HolickMF, ChenTC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr, 2008, 87(4): 1080s-1086s

[5] MathieuC, GysemansC, GiuliettiA, et al.. Vitamin D and diabetes. Diabetologia, 2005, 48(7): 1247-1257

[6] SandlerS, BuschardK, BendtzenK. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro. Immunol Lett, 1994, 41(1): 73-77

[7] NormanAW, FrankelJB, HeldtAM, et al.. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 1980, 209(4458): 823-825

[8] de Souza SantosR, ViannaLM. Effect of cholecalciferol supplementation on blood glucose in an experimental model of type 2 diabetes mellitus in spontaneously hypertensive rats and Wistar rats. Clin Chim Acta, 2005, 358(1–2): 146-150

[9] OrwollE, RiddleM, PrinceM. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr, 1994, 59(5): 1083-1087

[10] ElseweidyMM, AminRS, AtteiaHH, et al.. Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats. Biomed Pharmacother, 2017, 85: 155-159

[11] ViloriaK, HewisonM, HodsonDJ. Vitamin D binding protein/GC-globulin: a novel regulator of alpha cell function and glucagon secretion. J Physiol, 2022, 600(5): 1119-1133

[12] WanH, WangY, XiangQ, et al.. Associations between abdominal obesity indices and diabetic complications: Chinese visceral adiposity index and neck circumference. Cardiovasc Diabetol, 2020, 19(1): 118

[13] WangY, WengP, WanH, et al.. Economic Status Moderates the Association Between Early-Life Famine Exposure and Hyperuricemia in Adulthood. J Clin Endocrinol Metab, 2020, 105(11): dgaa523

[14] ChenY, ChengJ, ChenY, et al.. Association between serum vitamin D and uric acid in the eastern Chinese population: a population-based cross-sectional study. BMC Endocr Disord, 2020, 20(1): 79

[15] LiQ, LuM, WangNJ, et al.. Relationship between Free Thyroxine and Islet Beta-cell Function in Euthyroid Subjects. Curr Med Sci, 2020, 40(1): 69-77

[16] XuY, WangL, HeJ, et al.. Prevalence and control of diabetes in Chinese adults. Jama, 2013, 310(9): 948-959

[17] BrissovaM, FowlerMJ, NicholsonWE, et al.. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem, 2005, 53(9): 1087-1097

[18] ZhaoH, ZhengC, ZhangM, et al.. The relationship between vitamin D status and islet function in patients with type 2 diabetes mellitus. BMC Endocr Disord, 2021, 21(1): 203

[19] HeaneyRP. Toward a physiological referent for the vitamin D requirement. J Endocrinol Invest, 2014, 37(11): 1127-1130

[20] EkwaruJP, ZwickerJD, HolickMF, et al.. The importance of body weight for the dose response relationship of oral vitamin D supplementation and serum 25-hydroxyvitamin D in healthy volunteers. PLoS One, 2014, 9(11): e111265

[21] AlkhatatbehMJ, Abdul-RazzakKK. Association between serum 25-hydroxyvitamin D, hemoglobin A1c and fasting blood glucose levels in adults with diabetes mellitus. Biomed Rep, 2018, 9(6): 523-530

[22] MirhosseiniN, VatanparastH, MazidiM, et al.. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab, 2017, 102(9): 3097-3110

[23] ZoppiniG, GallettiA, TargherG, et al.. Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS One, 2013, 8(12): e82733

[24] WangN, WangC, ChenX, et al.. Vitamin D, prediabetes and type 2 diabetes: bidirectional Mendelian randomization analysis. Eur J Nutr, 2020, 59(4): 1379-1388

[25] PittasAG, Dawson-HughesB, SheehanP, et al.. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med, 2019, 381(6): 520-530

[26] RyuOH, LeeS, YuJ, et al.. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J, 2014, 61(2): 167-176

[27] BouillonR, ManousakiD, RosenC, et al.. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol, 2022, 18(2): 96-110

[28] Al-SofianiME, JammahA, RaczM, et al.. Effect of Vitamin D Supplementation on Glucose Control and Inflammatory Response in Type II Diabetes: A Double Blind, Randomized Clinical Trial. Int J Endocrinol Metab, 2015, 13(1): e22604

[29] JafariT, FaghihimaniE, FeiziA, et al.. Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: A randomised controlled clinical trial. Clin Nutr, 2016, 35(1): 67-76

[30] BarreaL, Frias-ToralE, PuglieseG, et al.. Vitamin D in obesity and obesity-related diseases: an overview. Minerva Endocrinol (Torino), 2021, 46(2): 177-192

[31] KjalarsdottirL, TerseySA, VishwanathM, et al.. 1,25-Dihydroxyvitamin D(3) enhances glucose-stimulated insulin secretion in mouse and human islets: a role for transcriptional regulation of voltage-gated calcium channels by the vitamin D receptor. J Steroid Biochem Mol Biol, 2019, 185: 17-26

[32] TakiishiT, DingL, BaekeF, et al.. Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term. Diabetes, 2014, 63(6): 2026-2036

[33] ElK, CapozziME, CampbellJE. Repositioning the Alpha Cell in Postprandial Metabolism. Endocrinology, 2020, 161(11): bqaa169

[34] ZhuL, DattaroyD, PhamJ, et al.. Intra-islet glucagon signaling is critical for maintaining glucose homeostasis. JCI Insight, 2019, 5(10): e127994

[35] Rodriguez-DiazR, TamayoA, HaraM, et al.. The Local Paracrine Actions of the Pancreatic alpha-Cell. Diabetes, 2020, 69(4): 550-558

[36] ViloriaK, NasteskaD, BriantLJB, et al.. Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion. Cell Rep, 2020, 31(11): 107761